SCHEMBL2919154

SCHEMBL2919154

CN(C)Cc1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.59
ALDH1A1 P00352 4/20 0.59
TSHR P16473 1/20 0.59
HPGD P15428 2/20 0.58
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
TAAR1 Q96RJ0 1/20 0.57
BCHE P06276 2/20 0.54
SRD5A2 P31213 1/20 0.52
HDAC1 Q13547 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ATM Q13315 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3798742 0.98 ACHE (0.58) ACHEALDH1A1TSHRHPGDNPC1
Bromide SCHEMBL4109635 0.98 ACHE (0.58) ACHEALDH1A1TSHRHPGDNPC1
Bromide SCHEMBL3799850 0.98 ACHE (0.58) ACHEALDH1A1TSHRHPGDNPC1
Hydrochloric Acid SCHEMBL27606790 0.98 ACHE (0.58) ACHEALDH1A1TSHRHPGDNPC1
SCHEMBL28884635 0.96 ACHE (0.56) ACHEALDH1A1TSHRHPGDNPC1
Cyclohexane SCHEMBL28149317 0.95 ACHE (0.55) ACHEALDH1A1TSHRHPGDNPC1
Hydrochloric Acid SCHEMBL9147976 0.93 TAAR1 (0.65) ACHEALDH1A1TSHRHPGDNPC1
Ethyl Chloride SCHEMBL29003402 0.93 ACHE (0.54) ACHEALDH1A1TSHRHPGDNPC1
SCHEMBL25137173 0.92 HRH3 (0.56) ACHEALDH1A1TSHRHPGDTAAR1
SCHEMBL27889204 0.90 ACHE (0.58) ACHEALDH1A1TSHRHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104185661-B The lubricity medical treatment device coating of low microgranule 苏尔莫迪克斯公司 2016-08-17 CN claimed
EP-1476496-B1 METHOD FOR CONTROLLING THE STABILITY OR THE DROPLETS SIZE OF SIMPLE WATER-IN-OIL EMULSIONS, AND STABILIZED SIMPLE WATER-IN-OIL EMULSIONS RHODIA CHIMIE SA (FR) 2016-07-20 EP claimed
CN-103289499-B A kind of photocurable Hydrophilic lubrication coating and preparation method thereof and using method SUN YAT-SEN UNIVERSITY (CN) 2015-12-02 CN claimed
CN-104185661-A Lubricious medical device coating with low particulates SURMODICS INC 2014-12-03 CN claimed
EP-2134312-B1 PERSONAL CARE COMPOSITIONS CONTAINING AT LEAST TWO CATIONIC POLYMERS AND AN ANIONIC SURFACTANT PROCTER & GAMBLE (US) 2014-10-29 EP claimed
CN-103289499-A Light-curing hydrophilic lubricating coating as well as preparation method and using method thereof UNIV SUN YAT SEN 2013-09-11 CN claimed
EP-2209824-B1 HIGH DEFINITION PRINTING WITH WATERBORNE INKS ON NON-POROUS SUBSTRATES RHODIA (US) 2012-08-08 EP claimed
EP-2226192-A1 Drying substances, preparation and use thereof Oridion Medical 1987 Ltd. (IL) 2010-09-08 EP claimed
CN-101410420-A Process for preparing a copolymer with controlled architecture, of telomer or block copolymer type, obtained from vinyl phosphonate monomers, by iodine transfer polymerization RHODIA OPERATIONS (FR) 2009-04-15 CN claimed
EP-1594623-B1 GRAFTING APPARTUS AND METHOD OF USING SURMODICS INC (US) 2007-04-11 EP claimed
EP-1747059-A1 PERVAPORATION COMPOSITE MEMBRANES McMaster University (CA) 2007-01-31 EP claimed
WO-2005102503-A1 PERVAPORATION COMPOSITE MEMBRANES MCMASTER UNIVERSITY (CA) 2005-11-03 WO claimed
US-20260108662-A1 LUBRICIOUS COATING FOR MEDICAL DEVICE SURMODICS INC (US) 2026-04-23 US disclosed
US-20250144182-A1 ACTIVE AGENT DEPOTS FORMED IN SITU FOR MAINTAINING LONG-TERM LESION PATENCY BANK OF MONTREAL, AS COLLATERAL AGENT 2025-05-08 US disclosed
CN-114981016-B Bottle suitable for storing liquid compositions having an aesthetic design suspended therein 宝洁公司 2024-11-19 CN disclosed
US-20240342347-A1 BIOFOULING RESISTANT COATINGS FOR MEDICAL DEVICES BANK OF MONTREAL, AS COLLATERAL AGENT 2024-10-17 US disclosed
EP-0740691-B1 PHOTOCURABLE FILM-FORMING ACRYLIC LATICES ATOCHEM ELF SA (FR) 1998-07-15 EP disclosed
EP-0740691-A1 PHOTOCURABLE FILM-FORMING ACRYLIC LATICES ELF ATOCHEM S.A. (FR) 1996-11-06 EP disclosed
CN-1107276-A Lithographic printing original plate and method for making plate using the same ASAHI CHEMICAL IND (JP) 1995-08-23 CN disclosed
WO-1995020016-A1 PHOTOCURABLE FILM-FORMING ACRYLIC LATICES ELF ATOCHEM S.A. (FR) 1995-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250144182-A1 ACTIVE AGENT DEPOTS FORMED IN SITU FOR MAINTAINING LONG-TERM LESION PATENCY PLAT, VEGFA, FGB ACHE 2276/4885ALDH1A1 3180/4885TSHR 2367/4885
US-20260108662-A1 LUBRICIOUS COATING FOR MEDICAL DEVICE MUC1, ADH1A, PTK2 ACHE 1657/4885ALDH1A1 45/4885TSHR 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.